MREO
Mereo BioPharma
MREO
MREO
82 hedge funds and large institutions have $267M invested in Mereo BioPharma in 2025 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 30 increasing their positions, 19 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
82
Holders Change
-7
Holders Change %
-7.87%
% of All Funds
1.1%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
11
Increased
30
Reduced
19
Closed
17
Calls
$8.29M
Puts
$3.35M
Net Calls
+$4.95M
Net Calls Change
+$3.2M
Top Buyers
| 1 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
+$4.39M |
| 2 |
Goldman Sachs
New York
|
+$2.61M |
| 3 |
Aberdeen Group
Edinburgh,
United Kingdom
|
+$2.28M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.95M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$1.13M |
Top Sellers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$13.7M |
| 2 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$6.01M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
-$3.83M |
| 4 |
Morgan Stanley
New York
|
-$3.78M |
| 5 |
UBS AM
Chicago,
Illinois
|
-$3.53M |
